Schedule 13D ownership disclosure
KINNATE BIOPHARMA INC
Security class unavailable · CUSIP: 49705R105
Event date: 2024-02-16
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 16.1000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000947871-24-000181
- Form type
- SC 13D
- Filer
- Kinnate Biopharma Inc.
- CIK
- CIK 1797768
- Filed
- Feb 21, 2024
- Reporting period
- Feb 16, 2024
- Description
- Schedule 13D beneficial ownership